Aprea Therapeutics (APRE) Return on Equity [ROE] (2023 - 2026)
Aprea Therapeutics' Return on Equity [ROE] came in at -33.03% for Q2 2026, up 69.14 percentage points from -102.17% a year earlier and up 13.53 percentage points from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Aprea Therapeutics' Return on Equity [ROE] was -83.37%, down 4.38 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of -24.35 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -78.98% in FY2024 (-6.34 pp), -72.64% in FY2023 (+229.13 pp), -301.77% in FY2022 (-242.76 pp) and -59.02% in FY2021.
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] in data going back to Q1 2023.
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -5.52 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2024 (a gain of 360.80 percentage points), and the weakest in Q3 2025 (a drop of 51.41 percentage points).
- Business Quant data shows APRE's Return on Equity [ROE] at -46.56% (Q1 2026), -113.33% (Q4 2025) and -113.59% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Aprea Therapeutics | 37.44 Mn | 37.44 Mn | - | -33.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.03% |
| Mar 31, 2026 | -46.56% |
| Dec 31, 2025 | -113.33% |
| Sep 30, 2025 | -113.59% |
| Jun 30, 2025 | -102.17% |
| Mar 31, 2025 | -87.53% |
| Dec 31, 2024 | -69.42% |
| Sep 30, 2024 | -62.18% |
| Jun 30, 2024 | -52.11% |
| Mar 31, 2024 | -61.03% |
| Dec 31, 2023 | -83.09% |
| Sep 30, 2023 | -66.11% |
| Jun 30, 2023 | -60.62% |
| Mar 31, 2023 | -421.83% |
API Access
Aprea Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();